• PDF / 599,232 Bytes
• 5 Pages / 595.276 x 790.866 pts Page_size
• 62 Downloads / 208 Views

DOWNLOAD

REPORT

CASE REPORT

Severe immune thrombocytopenic purpura in critical COVID‑19 Valérie Lévesque1 · Émilie Millaire1 · Daniel Corsilli2 · Benjamin Rioux‑Massé3 · François‑Martin Carrier2,3,4,5  Received: 1 June 2020 / Revised: 18 June 2020 / Accepted: 24 June 2020 © Japanese Society of Hematology 2020

Abstract COVID-19 is a new disease with many undescribed clinical manifestations. We report herein a case of severe immune thrombocytopenic purpura (ITP) in a critical COVID-19 patient. A patient presented a severe episode of immune thrombocytopenia (

Recommend Documents

Dapsone Induced Agranulocytosis and Hemolytic Anemia in Immune Thrombocytopenic Purpura

165 102 120KB

Quality of Life in Immune Thrombocytopenic Purpura: China Perspectives

180 80 268KB

Romiplostim: a guide to its use in immune (idiopathic) thrombocytopenic purpura

165 24 95KB

Diagnosis and Management of Thrombotic Thrombocytopenic Purpura

150 104 28MB

Immune-mediated thrombotic thrombocytopenic purpura in patients with and without systemic lupus erythematosus: a retrosp

163 21 574KB

Retinal involvement in acute thrombotic thrombocytopenic purpura: a case report

212 121 571KB

Rituximab prolongs the time to relapse in patients with immune thrombotic thrombocytopenic purpura: analysis of off-labe

168 2 978KB

Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study

165 110 895KB

Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A 2 receptor antib

153 16 1MB

Concomitant thrombotic thrombocytopenic purpura and ANCA-associated vasculitis in an adolescent

151 39 168KB

Obesity is associated with severe clinical course in children with Henoch-Schonlein purpura

143 15 267KB

Unraveling the Immune Response in Severe COVID-19

134 28 166KB